A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups (2010-2017)

Expert Review of Respiratory Medicine

Volumn 11, Issue 8, 2017, Pages 617-630

  Wilson, Amanda ^a   Guillaumier, Ashleigh ^b   George, Johnson ^c   Denham, Alexandra ^b   Bonevski, Billie ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

homeless persons; indigenous populations; low income population; mentally ill; prisoners; review; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; COTININE; NORTRIPTYLINE;

BEHAVIOR THERAPY; DRUG THERAPY; FOLLOW UP; HUMAN; JUVENILE; MENTAL DISEASE; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; PRISONER; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SOCIAL STATUS; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; BEHAVIORAL MEDICINE; CHILD; COUNSELING; FEMALE; MALE; MIDDLE AGED; POVERTY; PSYCHOLOGY; SMOKING; THERAPY; TREATMENT OUTCOME; VULNERABLE POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIORAL MEDICINE; CHILD; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; POVERTY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 85021950177     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1080/17476348.2017.1340836     Document Type: Review

References (58)

1. Australian Institute of Health and Welfare, The health of Australia’s prisoners 2015. Cat. no. PHE 207. 2015:Canberra:AIHW.
2. Nagelhout, G.E., et al., Socioeconomic and country variations in cross-border cigarette purchasing as tobacco tax avoidance strategy. Findings from the ITC Europe Surveys. Tobacco control, 2013:p. tobaccocontrol-2012-050838.
3. Centers for Disease Control and Prevention. Best practices user guide:health equity in tobacco prevention and control. Atlanta (GA):U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2015.
4. AIHW 2014. National drug strategy household survey detailed report:2013. Drug statistics series no. 28. Cat. no. PHE 183. Canberra:AIHW.
5. Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas:an overview of the study on low prevalence disorders. Aust N Z J Psychiatry. 2000;34(2):221–236.
6. Cooper J, Mancuso SG, Borland R, et al. Tobacco smoking among people living with a psychotic illness:the second Australian survey of psychosis. Aust N Z J Psychiatry. 2012;46(9):851–863.
7. Government A, National Tobacco Strategy 2012-2018. 2012 [cited 2017 28May 2017]; Available from:http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/national_ts_2012_2018_html.
8. Bryant J, Bonevski B, Paul C., A survey of smoking prevalence and interest in quitting among social and community service organisation clients in Australia:a unique opportunity for reaching the disadvantaged. BMC Public Health. 2011;11(1):827.•• This is the first systematic review of smoking cessation interventions for disadvantaged groups, and the basis for the current review.
9. World Health Organization. WHO report on the global tobacco epidemic. Geneva, Switzerland:World Health Organization; 2015.
10. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010:a systematic analysis for the global burden of disease Study 2010. The Lancet. 2013;380(9859):2224–2260.
11. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia:retrospective analysis of population based registers. Bmj. 2013;346:f2539.
12. Baggett TP, Hwang SW, O’Connell JJ, et al. Mortality among homeless adults in Boston:shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189–195.
13. Vos T, Barker B, Begg S, et al. Burden of disease and injury in aboriginal and torres strait islander peoples:the indigenous health gap. Int J Epidemiol. 2009;38(2):470–477.
14. Australian Institute of Health and Welfare, contribution of chronic disease to the gap in adult mortality between aboriginal and torres strait islander and other Australians. Cat. no. IHW 48. 2011:Canberra:AIHW.
15. Australian Bureau of Statistics. australian aboriginal and torres strait islander health survey:first results, Australia, 2012-13. 2014; [cited 2017 Mar 14]. Available from:http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/39E15DC7E770A144CA257C2F00145A66?opendocument.
16. Doll R, Exadaktylos A, Roeder C, et al. Mortality in relation to smoking:50 years’ observations on male British doctors. Bmj. 2004;328(7455):1519.
17. Siahpush M, Borland R, Scollo M. Smoking and financial stress. Tob Control. 2003;12(1):60–66.
18. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness:a population-based prevalence study. Jama. 2000;284(20):2606–2610.
19. Parrott A. Smoking cessation leads to reduced stress, but why? Int J Addict. 1995;30(11):1509–1516.
20. Chapman S, Freeman B. Markers of the denormalisation of smoking and the tobacco industry. Tob Control. 2008;17(1):25–31.
21. Paul CL, Ross S, Bryant J, et al. The social context of smoking:a qualitative study comparing smokers of high versus low socioeconomic position. BMC Public Health. 2010;10(1):211.
22. Bricker J, Leroux BG, Peterson AV, et al. Nine‐year prospective relationship betweenparental smoking cessation and children’s daily smoking. Addiction. 2003;98(5):585–593.
23. Kontis V, Mathers CD, Rehm J, et al. Contribution of six risk factors to achieving the 25× 25 non-communicable disease mortality reduction target:a modelling study. The Lancet. 2014;384(9941):427–437.
24. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. The Lancet. 2011;377(9775):1438–1447.
25. Passey M, Bonevski B. The importance of tobacco research focusing on marginalized groups. Addiction. 2014;109(7):1049–1051.
26. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. Bmj. 2015;351:h4065.
27. Bonevski B, Randell M, Paul C, et al. Reaching the hard-to-reach:a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14(1):42.
28. Kotz D, West R. Explaining the social gradient in smoking cessation:it’s not in the trying, but in the succeeding. Tob Control. 2009;18(1):43–46.
29. Álvarez Gutiérrez FJ, Ferrer Galván M, Ruiz Bernal A, et al. Predictors of 10‐year smoking abstinence in smokers abstinent for 1 year after treatment. Addiction. 2016;111(3):545–551.
30. Bryant J, Bonevski B, Paul C, et al. A systematic review and meta‐analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction. 2011;106(9):1568–1585.
31. Effective Public Health Practice Project. Quality Assessment Tool for Quantitative Studies Dictionary. 2009; [cited 2017 Mar 4]. Available from:http://www.ephpp.ca/tools.html.
32. Effective Public Health Practice Project. Quality Assessment Tool for Quantative Studies. 2010; [cited 2017 Mar 4]. Available from:http://www.ephpp.ca/tools.html.
33. Okuyemi KS, Goldade K, Whembolua G-L, et al. Motivational interviewing to enhance nicotine patch treatment for smoking cessation among homeless smokers:a randomized controlled trial. Addiction. 2013;108(6):1136–1144.
34. Marley JV, Atkinson D, Kitaura T, et al. The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting. BMC Public Health. 2014;14(1):32.
35. Eades SJ, Sanson-Fisher RW, Panaretto K. An intensive smoking intervention for pregnant aboriginal and torres strait islander women:a randomised controlled trial. Med J Aust. 2013;198(1):23.
36. Cropsey KL, Clark CB, Zhang X, et al. Race and medication adherence moderate cessation outcomes in criminal justice smokers. Am J Prev Med. 2015;49(3):335–344.
37. Richmond R, Indig D, Butler T, et al. A randomized controlled trial of a smoking cessation intervention conducted among prisoners. Addiction. 2013;108(5):966–974.
38. Davis JM, Aziz AA, Aminudin N. Pilot randomized trial on mindfulness training for smokers in young adult binge drinkers. BMC Complement Altern Med. 2013;13(1):215.
39. Christiansen BA, Reeder KM, TerBeek EG, et al. Motivating low socioeconomic status smokers to accept evidence-based smoking cessation treatment:a brief intervention for the community agency setting. Nicotine Tob Res. 2015;17(8):1002–1011.
40. Bennett ME, Brown CH, Li L, et al. Smoking cessation in individuals with serious mental illness:a randomized controlled trial of two psychosocial interventions. J Dual Diagn. 2015;11(3–4):161–173.
41. Bernard P, Ninot G, Cyprien F, et al. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms:A Randomized Controlled Pilot Trial. J Dual Diagn. 2015;11(3–4):205–216.
42. Patten, C.A., et al. Supervised, vigorous intensity exercise intervention for depressed female smokers:a pilot study. Nicotine & Tobacco Research. 2016. ntw208. Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
43. Prochaska JJ, Hall SE, Delucchi K, et al. Efficacy of initiating tobacco dependence treatment in inpatient psychiatry:a randomized controlled trial. Am J Public Health. 2014;104(8):1557–1565.•• Prochaska et al. demonstrated that significantly higher 7-day PPA at 3 months (13.9% vs 3.2%), 6 months (14.4% vs 6.5%) and 18-months (20% vs 7.7%) (all p’s<0.05) when participants received a computer-delivered tailored motivational program (repeated at 3 and 6 months) together with a cessation counseling session and a 10-week course of NRT.
44. Rogers ES, Smelson DA, Gillespie CC, et al. Telephone smoking-cessation counseling for smokers in mental health clinics:a patient-randomized controlled trial. Am J Prev Med. 2016;50(4):518–527.•• Rogers et al. found participants receiving specialized telephone counseling were more likely to report 30-day abstinence at 6 months than participants in the quitline control group (26% vs 18%, p < 0.05)(52).
45. Steinberg ML, Williams JM, Stahl NF, et al. An adaptation of motivational interviewing increases quit attempts in smokers with serious mental illness. Nicotine Tob Res. 2016;18(3):243–250.• Stockings et al. found that participants receiving self-help materials and a motivational interview upon discharge coupled with a 12-week course of NRT and telephone counselling over a 4-month period resulted in significantly higher 7-day PPA at 4-months compared to those receiving routine inpatient care only; although significant differences were not detected at the 1-week, 2- or 6-month follow-up timepoints.
46. Stockings, E.A., et al. Impact of a postdischarge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility:a randomized controlled trial. Nicotine & Tobacco Research. 2014;16(11):1417–1428. doi:10.1093/ntr/ntu097.
47. Brown J, Michie S, Geraghty AWA, et al. Internet-based intervention for smoking cessation (StopAdvisor) in people with low and high socioeconomic status:a randomised controlled trial. Lancet Respir Med. 2014;2(12):997–1006.
48. Patten CA, Fadahunsi O, Hanza MMK, et al. Tobacco cessation treatment for Alaska Native adolescents:group randomized pilot trial. Nicotine Tob Res. 2014;16(6):836–845.
49. Haas J, Linder J, Park E. Proactive tobacco cessation outreach to smokers of low socioeconomic status:a randomized clinical trial. JAMA Intern Med. 2015;175(2):218–226.• Haas et al. (45) was a similar design to Fu et al with an intervention of telephone counselling and free NRT for 6 weeks for participants with low incomes versus usual care for the control group. Participants in the intervention group had a significantly higher likelihood of reporting they had quit smoking than the control (17.8% versus 8.1%, p = 0.001) however this was not biochemically verified.
50. Cherrington A, Williams JH, Foster PP, et al. Narratives to enhance smoking cessation interventions among African-American smokers, the ACCE project. BMC Res Notes. 2015;8(1):567.
51. Davis JM, Goldberg SB, Anderson MC, et al. Randomized trial on mindfulness training for smokers targeted to a disadvantaged population. Subst Use Misuse. 2014;49(5):571–585.
52. Bock BC, Papandonatos GD, De Dios MA, et al. Tobacco cessation among low-income smokers:motivational enhancement and nicotine patch treatment. Nicotine Tob Res. 2014;16(4):413–422.
53. Davis JM, Manley AR, Goldberg SB, et al. Randomized trial comparing mindfulness training for smokers to a matched control. J Subst Abuse Treat. 2014;47(3):213–221.•• Davis et al. (41) compared mindfulness training to a control group given access to a phone quit line and found a significant difference in abstinence between groups (38.7% versus 20.6%, p = 0.05) at four and 24 weeks.
54. Etter J-F, Schmid F. Effects of large financial incentives for long-term smoking cessation:a randomized trial. J Am Coll Cardiol. 2016;68(8):777–785.•• Etter et al. (43) using financial incentives, saw a significant difference between the intervention and control group for rates of continuous abstinence between months 6 and 18 (9.5% versus 3.7%, p = 0.001). Rates of 7-day abstinence were also significantly higher in the incentive group at 3 months (54.9% versus 11.9, p = 0.001), 6 months (44.6% versus 11.1, p = 0.001) and 18 months (18.2% versus 11.45, p = 0.006).
55. Fu SS, Van Ryn M, Nelson D, et al. Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers:a randomised clinical trial. Thorax. 2016;71(5):446–453.• Fu et al. (44) used a large sample (2406) of people attending publically funded health care programs for low income populations. The intervention group were given access to free NRT and intensive, telephone proactive behavioural counselling and a quit smoking manual. The primary outcome of 6 months prolonged abstinence was significantly higher in the intervention group (16.5% versus 12.1%, p = 0.006). However, this was based on self-report with no bio-verification.
56. Tidey JW, Rohsenow DJ, Kaplan GB, et al. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 2011;217(2):279–287.
57. Hartmann-Boyce J, Stead LF, Cahill K, et al. Efficacy of interventions to combat tobacco addiction:cochrane update of 2013 reviews. Addiction. 2014;109(9):1414–1425.
58. Twyman L, Bonevski B, Paul C, et al. Perceived barriers to smoking cessation in selected vulnerable groups:a systematic review of the qualitative and quantitative literature. BMJ Open. 2014;4:12.